JP2017160268A5 - - Google Patents

Download PDF

Info

Publication number
JP2017160268A5
JP2017160268A5 JP2017123029A JP2017123029A JP2017160268A5 JP 2017160268 A5 JP2017160268 A5 JP 2017160268A5 JP 2017123029 A JP2017123029 A JP 2017123029A JP 2017123029 A JP2017123029 A JP 2017123029A JP 2017160268 A5 JP2017160268 A5 JP 2017160268A5
Authority
JP
Japan
Prior art keywords
pharmaceutical
composition
antiarrhythmic
administration
minutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017123029A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017160268A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017160268A publication Critical patent/JP2017160268A/ja
Publication of JP2017160268A5 publication Critical patent/JP2017160268A5/ja
Pending legal-status Critical Current

Links

JP2017123029A 2009-03-18 2017-06-23 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 Pending JP2017160268A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21038209P 2009-03-18 2009-03-18
US61/210,382 2009-03-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015149197A Division JP2015193657A (ja) 2009-03-18 2015-07-29 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018204914A Division JP6715305B2 (ja) 2009-03-18 2018-10-31 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法

Publications (2)

Publication Number Publication Date
JP2017160268A JP2017160268A (ja) 2017-09-14
JP2017160268A5 true JP2017160268A5 (https=) 2017-10-26

Family

ID=42739985

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2012500945A Withdrawn JP2012520890A (ja) 2009-03-18 2010-03-18 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法
JP2015149197A Withdrawn JP2015193657A (ja) 2009-03-18 2015-07-29 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法
JP2017123029A Pending JP2017160268A (ja) 2009-03-18 2017-06-23 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法
JP2018204914A Active JP6715305B2 (ja) 2009-03-18 2018-10-31 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法
JP2019162836A Active JP7071949B2 (ja) 2009-03-18 2019-09-06 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2012500945A Withdrawn JP2012520890A (ja) 2009-03-18 2010-03-18 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法
JP2015149197A Withdrawn JP2015193657A (ja) 2009-03-18 2015-07-29 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2018204914A Active JP6715305B2 (ja) 2009-03-18 2018-10-31 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法
JP2019162836A Active JP7071949B2 (ja) 2009-03-18 2019-09-06 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法

Country Status (9)

Country Link
US (5) US8974828B2 (https=)
EP (3) EP3552603B1 (https=)
JP (5) JP2012520890A (https=)
AU (1) AU2010226613B2 (https=)
CA (2) CA2835771C (https=)
DK (1) DK2413902T3 (https=)
ES (3) ES3003038T3 (https=)
PL (1) PL2413902T3 (https=)
WO (1) WO2010107964A1 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2835771C (en) 2009-03-18 2017-01-24 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
IL298116A (en) 2010-12-22 2023-01-01 Syqe Medical Ltd Method and system for drug delivery
US9713687B2 (en) 2012-08-21 2017-07-25 Philip Morris Usa Inc. Ventilator aerosol delivery system with transition adapter for introducing carrier gas
US11191755B2 (en) 2014-01-17 2021-12-07 Cornell University Compositions and methods for providing cardioprotective effects
TWI590837B (zh) * 2014-03-25 2017-07-11 林信湧 一種用於治療心臟病之吸入式醫藥組成物及其備製方法
EP3160565B1 (en) * 2014-06-30 2021-08-18 Syqe Medical Ltd. Devices and systems for pulmonary delivery of active agents
US11298477B2 (en) 2014-06-30 2022-04-12 Syqe Medical Ltd. Methods, devices and systems for pulmonary delivery of active agents
KR102482733B1 (ko) 2014-06-30 2022-12-29 사이키 메디컬 엘티디. 유동 조절 흡입기 디바이스
PL3160552T3 (pl) 2014-06-30 2020-03-31 Syqe Medical Ltd. Wkład z dawką leku dla urządzenia inhalacyjnego
US10668015B2 (en) 2015-01-20 2020-06-02 Incarda Therapeutics, Inc. Unit aerosol doses for anticoagulation
EP4428119A3 (en) * 2015-04-14 2024-11-13 Milestone Pharmaceuticals Inc. Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof
EP3851102B1 (en) 2016-01-06 2025-04-16 Syqe Medical Ltd. Low dose therapeutic treatment
CN114847965A (zh) 2016-02-01 2022-08-05 英凯达治疗公司 电子监测联合吸入药理学疗法管理心律失常
CA3060702A1 (en) * 2017-05-10 2018-11-15 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
ES3040411T3 (en) * 2018-03-22 2025-10-30 Incarda Therapeutics Inc A novel method to slow ventricular rate
WO2019236694A1 (en) * 2018-06-05 2019-12-12 Incarda Therapeutics, Inc. Methods for diagnosing brugada syndrome using an aerosol
WO2019241597A1 (en) * 2018-06-14 2019-12-19 Cornell University Compositions and methods for providing cardioprotective effects
US10512620B1 (en) 2018-08-14 2019-12-24 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US12396970B2 (en) 2021-08-20 2025-08-26 AltaThera Pharmaceuticals LLC Anti-arrhythmic compositions and methods
US11344518B2 (en) 2018-08-14 2022-05-31 AltaThera Pharmaceuticals LLC Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US11007185B2 (en) 2019-08-01 2021-05-18 Incarda Therapeutics, Inc. Antiarrhythmic formulation
KR102891439B1 (ko) * 2019-08-01 2025-11-25 인카다 테라퓨틱스, 인크. 항부정맥 제제
CN116867483A (zh) * 2020-12-17 2023-10-10 英凯达治疗公司 用于诱导患有房性心律失常的对象的心脏复律的试剂盒和方法
AU2021400335A1 (en) * 2020-12-17 2023-06-22 Incarda Therapeutics, Inc. Kits and methods for induction of cardioversion in subjects with atrial arrhythmias

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1016489B (it) 1974-03-18 1977-05-30 Isf Spa Inalatore
SE408265B (sv) 1975-12-12 1979-06-05 Draco Ab Anordning for koldioxiddriven endosaerosol, avsedd for inhalering
US4247066A (en) 1978-02-21 1981-01-27 General Dynamics Corporation Airfoil variable cambering device and method
IT1116047B (it) 1979-04-27 1986-02-10 Sigma Tau Ind Farmaceuti Dispositivo per la rapida inalazione di farmaci in polvere da parte di persone sofferenti di asma
DE3634952A1 (de) 1986-10-14 1988-04-21 Bayer Ag Imidazo-pyrrolo-pyridin-derivate
JP3202705B2 (ja) * 1987-11-06 2001-08-27 リサーチ ディベロップメント ファンデーション 医療用のリポソームおよび薬物含有リポソームのエアゾールの小粒子
US4962095A (en) * 1989-02-15 1990-10-09 E. R. Squibb & Sons, Inc. Method of reducing pre-and post-ischemic myocardial arrhythmias and fibrillation
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
WO1993000951A1 (en) 1991-07-02 1993-01-21 Inhale, Inc. Method and device for delivering aerosolized medicaments
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
NZ281112A (en) 1994-03-07 1998-04-27 Inhale Therapeutic Syst Powdered insulin delivered as an aerosol
ES2245780T3 (es) 1994-05-18 2006-01-16 Nektar Therapeutics Metodos y composiciones para la formulacion de interferones como un polvo seco.
JP3388896B2 (ja) 1994-08-08 2003-03-24 株式会社日立ユニシアオートモティブ 吸入式投薬器
US5693609A (en) 1994-11-17 1997-12-02 Eli Lilly And Company Acylated insulin analogs
ES2237767T3 (es) 1995-04-14 2005-08-01 Nektar Therapeutics Composiciones farmaceuticas en polvo que tienen una dispersabilidad mejorada.
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5855913A (en) 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5985309A (en) 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6503480B1 (en) 1997-05-23 2003-01-07 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6077543A (en) 1996-12-31 2000-06-20 Inhale Therapeutic Systems Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
WO1999016420A1 (en) 1997-09-29 1999-04-08 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in nebulizers
US20020017295A1 (en) 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
CN1169520C (zh) 1997-09-29 2004-10-06 耐科塔医药公司 多孔微粒及其使用方法
US6541479B1 (en) * 1997-12-02 2003-04-01 Massachusetts College Of Pharmacy Calcium channel blockers
US6257233B1 (en) 1998-06-04 2001-07-10 Inhale Therapeutic Systems Dry powder dispersing apparatus and methods for their use
DE19835346A1 (de) 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
DE69935154T2 (de) 1998-11-12 2007-10-25 Inc. Transave Inhalationssystem
EP1181069B1 (en) 1999-05-28 2006-06-28 Nektar Therapeutics Apparatus and method for aerosolising a powder pharmaceutical composition
DE60128902T2 (de) * 2000-04-17 2008-02-14 Vectura Ltd., Chippenham Formulierungen zur verwendung in inhalationsvorrichtungen
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
ES2525087T5 (es) 2000-05-10 2018-06-28 Novartis Ag Polvos basados en fosfolípidos para administración de fármacos
US6357490B1 (en) 2000-08-22 2002-03-19 Advanced Inhalation Research, Inc. System, method and apparatus for filling containers
FI20002215A0 (fi) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
CA2432319A1 (en) 2000-12-21 2002-07-18 Nektar Therapeutics Pulmonary delivery of polyene antifungal agents
WO2002080859A2 (en) 2001-03-20 2002-10-17 Glaxo Group Limited Inhalation drug combinations
US6766799B2 (en) 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
US20080038363A1 (en) * 2001-05-24 2008-02-14 Zaffaroni Alejandro C Aerosol delivery system and uses thereof
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Pharmaceuticals, Inc. Delivery of drug esters through an inhalation route
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7090830B2 (en) * 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
JP4795637B2 (ja) * 2001-09-28 2011-10-19 カーブ テクノロジー,インコーポレイティド 鼻ネブライザー
ATE418991T1 (de) * 2002-04-18 2009-01-15 Cv Therapeutics Inc Methode zur behandlung von herzrhythmusstörungen mit einem a1 adenosin agonist zusammen mit einem beta blocker
US8245708B2 (en) 2002-05-07 2012-08-21 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
US7607436B2 (en) 2002-05-06 2009-10-27 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
EP1515768B1 (en) 2002-05-07 2013-11-06 The State University of New York at Stony Brook Devices for targeted endobronchial therapy
TR200502522T2 (tr) 2002-12-31 2005-09-21 Nektar Therapeutics Çözünmez bir aktif madde içeren farmasötik formülasyon
MXPA05011428A (es) * 2003-04-24 2006-05-31 Aderis Pharmaceuticals Inc Metodo de tratamiento de fibrilacion atrial o trepidacion auricular.
WO2005018635A2 (en) * 2003-08-07 2005-03-03 Cardiome Pharma Corp. Ion channel modulating activity i
CN101001633A (zh) * 2004-05-21 2007-07-18 特兰萨夫公司 肺病和肺病前期病症的治疗
US8569277B2 (en) * 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition
TWI396541B (zh) 2005-10-10 2013-05-21 Boehringer Ingelheim Int 用於治療呼吸疾病之新穎藥物組合
ITMI20051999A1 (it) * 2005-10-21 2007-04-22 Eratech S R L Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
JP4931930B2 (ja) * 2005-10-21 2012-05-16 メルク・シャープ・エンド・ドーム・コーポレイション カリウムチャネル阻害剤
CL2007002689A1 (es) 2006-09-18 2008-04-18 Vitae Pharmaceuticals Inc Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
RU2463085C2 (ru) 2006-10-25 2012-10-10 Новартис Аг Аппарат для распыления порошка, способ его изготовления и применения и его компоненты
EP2099295A4 (en) 2006-11-22 2010-02-24 Reliant Pharmaceuticals Inc PROPHYLAXIS AND TREATMENT OF AURICULAR FIBRILLATION WITH OMEGA-3 FATTY ACIDS
TW200840578A (en) 2006-12-15 2008-10-16 Procter & Gamble Compositions of azimilide dihydrochloride
WO2008134630A1 (en) * 2007-04-30 2008-11-06 Apt Pharmaceuticals Dexrazoxane compounds for cardioprotection
US20080275036A1 (en) * 2007-05-02 2008-11-06 Apt Pharmaceuticals, Inc. Prevention and treatment of cardiac conditions
US20110144125A1 (en) 2008-08-14 2011-06-16 The Uab Research Foundation Anti-Arrhythmia Agents, Methods of Their Use, Methods of Their Identification and Kits Therefore
US8501727B2 (en) 2008-08-22 2013-08-06 Milestone Pharmaceuticals Inc. Short acting benzothiazepine calcium channel blockers and uses thereof
CA2778604C (en) * 2008-09-23 2021-10-05 Laboratory Skin Care, Inc. Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
CA2835771C (en) 2009-03-18 2017-01-24 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration

Similar Documents

Publication Publication Date Title
JP2017160268A5 (https=)
JP2015193657A5 (https=)
JP2019203032A5 (https=)
JP2020519628A5 (https=)
Tsai et al. Myocardial protective effect of honokiol: an active component in Magnolia ofpcinalis
JP2011522876A (ja) 永続性心房細動を予防するためのドロネダロン
JP2014514271A5 (https=)
Piotrowski et al. Antazoline for rapid termination of atrial fibrillation during ablation of accessory pathways
WO2024193467A1 (zh) 柏科植物提取物及其在制备心律失常的预防和治疗药物中的应用
Paraskevaidis et al. Narrow QRS complex in idiopathic (fascicular) left ventricular tachycardia
Karadas et al. Myocardial infarction due to lightning strike
CN101698050B (zh) 一种中药组合物在制备治疗阵发性心房颤动药物中的应用
Kaya et al. Adverse Cardiac Effects of Decongestants Agents
CN104873527B (zh) 一种用于治疗心血管疾病的天然药物组合物
Oral et al. Comparison of amiodarone versus ibutilide for the prevention of immediate recurrences of atrial fibrillation during pulmonary vein isolation
Kukar et al. Idiopathic fascicular left ventricular tachycardia: case report and review of the literature
Silva et al. Radiofrequency ablation in the treatment of focal atrial fibrillation using circumferential mapping and segmentary disconnection of pulmonary veins
Voskoboinik et al. Ventricular fibrillation storm in a young man with early repolarisation abnormality: the role of isoprenaline and quinidine.
CN105963292B (zh) 一种用于心肌梗死治疗的药物组合物及其应用
Rathod et al. PREPARATIONS AND EVALUATION ASHWAGANDHA CAPSULE FOR ANTIARRHYTHMIC PROPERTIES
Santinelli et al. Paroxysmal supraventricular tachycardia: experience with propafenone
Carmo et al. P1813 Best voltage threshold to localize ablation targets in patients with ventricular tachycardia using rhythmia mapping system
Oxford et al. ECG of the Month
Yuzawa et al. High Incidence of Inappropriate ICD Therapies in Young Patients with Catecholaminergic Polymorphic Ventricular Tachycardia
CN102579456A (zh) 山楂酸抗心律失常中的新用途